Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab

MLA

Maxwell P. Krist, et al. “Immunogenicity of Repeat COVID-19 MRNA Vaccinations in a Patient with Myasthenia Gravis Receiving Mycophenolate, Prednisone, and Eculizumab.” Journal of Translational Autoimmunity, vol. 4, Jan. 2021, p. 100114. EBSCOhost, https://doi.org/10.1016/j.jtauto.2021.100114.

APA

Maxwell P. Krist, Gregory Pepper, Lisa C. Plymate, & David M. Koelle. (2021). Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab. Journal of Translational Autoimmunity, 4, 100114. https://doi.org/10.1016/j.jtauto.2021.100114

Chicago

Maxwell P. Krist, Gregory Pepper, Lisa C. Plymate, and David M. Koelle. 2021. “Immunogenicity of Repeat COVID-19 MRNA Vaccinations in a Patient with Myasthenia Gravis Receiving Mycophenolate, Prednisone, and Eculizumab.” Journal of Translational Autoimmunity 4 (January): 100114. doi:10.1016/j.jtauto.2021.100114.